Stay updated on Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page.

Latest updates to the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe Study Record History now includes a new revision tag v3.5.4 and removes the previous v3.5.3 entry, indicating an update to the study record's metadata.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new 2026-04-29 version shows posted results and related sections (adverse events, outcome measures, results), and the earlier 2025-03-13 'Results Submitted' entry was removed.SummaryDifference0.6%

- Check22 days agoChange DetectedThe page’s displayed interface revision/version updates from v3.5.2 to v3.5.3, reflecting a change to the site tooling rather than the underlying trial record content.SummaryDifference0.1%

- Check29 days agoChange DetectedA new revision, v3.5.2, has been added to the history, replacing the previous v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Study Design, Study Status, and Document Section. Also updated the record with a Quality Control status note 'Has Not Concluded' and a version update to 3.5.0 (2026-02-25).SummaryDifference1%

- Check65 days agoChange DetectedRevision: v3.4.3 added; Revision: v3.4.2 removed.SummaryDifference0.1%

Stay in the know with updates to Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab and Platinum Chemotherapy Combo in Lung Cancer Clinical Trial page.